Navigation Links
Risk of dementia reduced hypertension drugs

According to a new study it is observed that reducing blood pressure by medication can reduce the risk of dementia by half. It is already known that hypertension (high blood pressure) increases the risk of vascular dementia// and Alzheimer's disease. In a study carried out by doctors in Dallas, the effect of lowering blood pressure on dementia rates has been examined.

A group of patients with systolic hypertension - with levels from 160 to 190 mm Hg - were looked at. For around four years, these patients took blood-pressure lowering drugs or placebo. Those on the medication had a 50 per cent lower risk of dementia. The study was then stopped in 1998, when it was realized that lowering blood pressure by medication had the effect of reducing stroke risk; it was considered unethical to keep people on placebo.

People are often told that they should keep on with blood pressure medication to cut their risk of having a heart attack. This new study emphasizes another potential benefit - keeping dementia at stand.


'"/>




Page: 1

Related medicine news :

1. Music aids in curing dementia
2. Hobbies prevent dementia
3. Moderate alcohol consumption protects against dementia
4. Alcohol decreases risk of dementia
5. Consuming fish prevents dementia risk
6. Drinking wine beneficial in dementia
7. Essential tremor can lead to dementia
8. Midlife obesity linked to risk of dementia
9. Obesity in the Middle age can increase risk of developing dementia
10. MRI for distinguishing between dementia and Alzheimer’s diseas
11. A word of caution issued by the FDA for those using antipsychotic drugs for dementia

Post Your Comments:
(Date:11/30/2009)...NESVILLE, Fla., Nov. 30 The launch...he availability of the first FDA-cleared, fully-au... analysis by a radiologist of suspicious breast le...d at the Radiological Society of North America 200...rtnership with leading experts in breast MRI, ONCA...
(Date:11/30/2009)... two years of development and extensive discussion...ality and Efficiency in Health Care (IQWiG) presen... cost and benefit. The Institute can now apply the...rded by the Federal Joint Committee (G-BA). The me... recommendations to the GKV-Spitzenverband [Nation...
(Date:11/30/2009)... Keynote speaker & Author Dr. Templ... Corpus Christi, TX (Vocus) Novem...ference is set to be held in Corpus Christi from ... 2009 at the American Bank Center., , , , ,The co...d to make a nearly $300,000 economic impact on the...
(Date:11/30/2009)...al skills improve with specially designed program,...Day News) -- A special, intensive early interventi...oosting IQ along with children,s language and soci...his fashion, many children are able to learn and m...ead author of the study, published online Nov. 30 ...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker...s available in its catalogue: ,, The Future of...es and targeted opportunities for older consumers ...uture-of-Senior-Nutrition-Key-ingredients-strategi...umers.html ,, Seniors, have emerged as a power...
Breaking Medicine News(10 mins):Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 2Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 3Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 4Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 5Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 6Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 7Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 8
...ormal-weight women who carry out lots of vigorous ...lop breast cancer than those who don,t exercise vi...tmenopausal American women, reported in BioMed Cen...re not overweight. , While an Investigator at the...
...oved laboratory efficiencies and standardization t... care, PLEASANTON, Calif., Oct. 30 Roche Mol...ood & Drug Administration (FDA) has approved,the C...he amount of Hepatitis C RNA in a patient,s blood....
...LOUIS, Oct. 30 Schering-Plough,Corporation (NYSE:...the,decision reached by a jury in Missouri related...f certain products sold by Warrick,Pharmaceuticals...ble laws and regulations governing reimbursement r...
...ing Pediatricians Refute MD Who Signed Prop 8 Ball...on Prop 8 campaign,today released a statement sign...ns announcing their joint opposition to Prop 8 and...sue., The pediatrician statement took issue with ...
...OLUMBIA, Mo. Long after a conflict, landmines rem...nd detonate them. According to the United Nations ...ried in 68 countries around the world. The UN est...he accuracy of a landmine radar system while minim...
...TANFORD, Calif. Investigators combing the genome ...le for triggering early-onset diabetes ,may be loo...ord ,University School of Medicine suggests. , Ea...lls in a person,s pancreas. , What triggers that ...
Other Medicine News:Health News:Vigorous activity protects against breast cancer 2Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 2Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 3Health News:Schering-Plough to Appeal Jury Decision in Missouri Reimbursement Case 2Health News:NO on Prop 8 Campaign Releases Statement by 300 California Pediatricians 2Health News:Engineer creating more sensitive, safer landmine detectors 2Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 2Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 3Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 4
(Date:11/30/2009)...wswire/ -- StemCyte, Inc. concluded an exclusive l...ia Sinica, the National Laboratory of Taiwan, for ...rty (IP) related to the treatment of Chronic Strok...ed by a team led by Professor John Lin, MD, PhD an...rrently the exclusive collaborator with StemCyte o...
(Date:11/30/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Inflammatory Disorders: Therapies That Sup...//www.reportlinker.com/p0165600/Inflammatory-Disor...-Response.html ,, The human immune system can ...oducing an exaggerated response to a foreign subst...
(Date:11/30/2009)...swire/ -- The Simmons law firm,s Trent Miracle wil...housands of women that were seriously injured afte...ill manufactured and marketed by Bayer Pharmaceuti...ct Litigation has ordered that all federal Yaz and...d and centralized for pretrial litigation in the S...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Nuisance or nutrient 3F Kudzu shows promise as a dietary supplement 55404 1Rutgers Camden developing enzyme function database 9702 1Rutgers Camden developing enzyme function database 9702 2Solta Medical Launches New Fraxel re 3Astore 28R 29 Dual Laser System 55402 1Solta Medical Launches New Fraxel re 3Astore 28R 29 Dual Laser System 55402 2Solta Medical Launches New Fraxel re 3Astore 28R 29 Dual Laser System 55402 3
...ter IVUS Sub-study Part of the Cardiovascular, Res...ses and Cures of Drug Eluti...Corporation,(Nasdaq: VOLC ) [TCT Booth #2013 Leve...asound (IVUS) and functional measurement (FM) tech...t major study designed to,examine the role of IVUS...
...INGTON, Oct. 22 Boston,Scientific Corporation (NY...III Clinical Trial, which continue to support the ...AXUS(R) Express2(TM) Paclitaxel-Eluting,Coronary S...clinical,evidence for the XIENCE(TM) V (PROMUS(TM)...lysis of the data was presented by Gregg W. Stone,...
Other Medicine Technology:Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 2Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 3Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 4Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 2Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 3Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 4
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products: